Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. Shareholder Equity 2017–2025
Bionano Genomics Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bionano Genomics Inc. shareholder equity as of December 31, 2025: 44.4M, a 25.58% increase year-over-year.
- Bionano Genomics Inc. shareholder equity for 2025 were 44.4M, a 25.58% increase from 2024.
- Bionano Genomics Inc. shareholder equity for 2024 were 35.4M, a 63.21% decrease from 2023.
- Bionano Genomics Inc. shareholder equity for 2023 were 96.2M, a 61.44% decrease from 2022.
- Bionano Genomics Inc. shareholder equity for 2022 were 249.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bionano Genomics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $44 |
| 2024 | $35 |
| 2023 | $96 |
| 2022 | $249 |
| 2021 | $337 |
| 2020 | $35 |
| 2019 | $4 |
| 2018 | $10 |
| 2017 | $-50 |
Bionano Genomics Inc. Shareholder Equity — FAQ
Bionano Genomics Inc. (BNGO) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNGO's shareholder equity history?
The chart and table above show Bionano Genomics Inc.'s shareholder equity by year and by quarter, including the growth rate.